GlassScriptPhysician profile
Catherine Marshall
NPI 1114070588
$6,722.18
in general payments reported to CMS, 2019-2025
7 companies · $3,213 in 2025
The $3,213 reported for 2025 was more than what 98% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $303 · 2023: $2,909 · 2024: $298 · 2025: $3,213.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,909 · Food and Beverage: $2,822 · Consulting Fee: $688.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,909.47 |
| Food and Beverage | $2,822.47 |
| Consulting Fee | $687.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $3,031.64 | 2022-2025 | Linq II, Corevalve Evolut R, Micra |
| Abbott Laboratories | $1,733.18 | 2023-2025 | Navitor, Aveir, Assurity |
| Boston Scientific Corporation | $796.74 | 2023-2025 | Watchman Access System, Watchman Flx, General - Therapies |
| Biotronik INC. | $687.50 | 2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $394.10 | 2022-2024 | Lifevest |
| Pfizer INC. | $58.22 | 2025 | |
| Mallinckrodt Hospital Products INC. | $20.80 | 2025 | Terlivaz |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Catherine Marshall listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.